Jason Scott Slakter, Director at Ohr Pharmaceutical Inc (OHRP), bought 29,630 shares at $6.75 ($200K) on 2015-02-06, disclosed to the SEC on 2015-02-10.
Open-market purchase of $200k OHRP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| OHRP | BUY | 2016-05-26 | $11K | — | Filing → |
| OHRP | BUY | 2016-05-25 | $89K | — | Filing → |
| OHRP | BUY | 2016-04-12 | $21K | — | Filing → |